true nature is a development stage company focused on consolidating businesses in the compound pharmacy industry that serve both the human and veterinary markets. starting in the southeast, the company intends to acquire compounders across the us that meet their criteria and present a complementary fit to the true nature platform. mission: to unlock the potential of the compounding pharmacy industry to improve human and animal health, serve unmet patient needs, elevate the dignity of skilled pharmacists, and build shareholder value through the delivery of quality, cost effective, and innovative healthcare products and pharmaceuticals to the world. vision: to become globally recognized for our best practices focused on driving quality, efficiency and sustainability in the compounding pharmaceutical industry, natural solutions for healthy living, and novel approaches for delivery of these solutions.
Company profile
Ticker
MITI
Exchange
Website
CEO
Lawrence Diamond
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
BRAIN TREE INTERNATIONAL INC, True Nature Holding, Inc., Trunity Holdings, Inc.
SEC CIK
Corporate docs
Subsidiaries
MitescoNA, LLC • The Good Clinic, LLC • Acelerar Healthcare Holdings, LTD ...
MITI stock data
Latest filings (excl ownership)
PRE 14C
Preliminary information
1 Sep 23
RW
Registration withdrawal request
29 Aug 23
8-K
Mitesco Appoints Mr. Allen Plunk to its Board of Directors
18 Jul 23
10-K
2022 FY
Annual report
14 Jul 23
8-K
Entry into a Material Definitive Agreement
6 Jul 23
8-K
Departure of Directors or Certain Officers
8 Jun 23
8-K
Mitesco Moves Emphasis to Acquisitions & Strategic Initiatives
16 May 23
8-K
Entry into a Material Definitive Agreement
17 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
8-K
Entry into a Material Definitive Agreement
17 Jan 23
Latest ownership filings
3
Lonnie Allen Plunk
18 Jul 23
4
Lawrence M. Diamond
10 Jul 23
4
Lawrence M. Diamond
30 Jan 23
4
Sheila Schweitzer
6 Dec 22
4
Faraz Naqvi
6 Dec 22
4
Juan Carlos Iturregui
6 Dec 22
4
Thomas Brodmerkel
6 Dec 22
4
Lawrence M. Diamond
6 Dec 22
4
Ingrid Jenny Lindstrom
6 Dec 22
4
Juan Carlos Iturregui
27 Jul 22
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 35.62 k | 35.62 k | 35.62 k | 35.62 k | 35.62 k | 35.62 k |
| Cash burn (monthly) | (no burn) | 94.07 k | 3.90 mm | 1.94 mm | (no burn) | 431.15 k |
| Cash used (since last report) | n/a | 820.59 k | 34.03 mm | 16.89 mm | n/a | 3.76 mm |
| Cash remaining | n/a | -784.97 k | -33.99 mm | -16.86 mm | n/a | -3.73 mm |
| Runway (months of cash) | n/a | -8.3 | -8.7 | -8.7 | n/a | -8.6 |
Institutional ownership, Q2 2022
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Jan 23 | Diamond Lawrence M. | Common Stock, par value $0.01 | Other | Acquire J | No | No | 4.38 | 666 | 2.92 k | 138,683 |
| 29 Nov 22 | Ingrid Jenny Lindstrom | Common Stock Purchase Warrant Common Stock | Buy | Acquire P | No | No | 0 | 37,500 | 0.00 | 37,500 |
| 29 Nov 22 | Diamond Lawrence M. | Common Stock Purchase Warrant Common Stock | Buy | Acquire P | No | No | 0 | 37,500 | 0.00 | 37,500 |
| 29 Nov 22 | Thomas Brodmerkel | Common Stock Purchase Warrant Common Stock | Buy | Acquire P | No | No | 0 | 37,500 | 0.00 | 37,500 |